Patient-centered care has been getting a lot of attention as the healthcare industry focuses on the Triple Aim of delivering better health outcomes, improving patient experience, and reducing the cost of care. In that vein, the Louis W. Sullivan Institute for Healthcare Innovation recently released 6 guiding principles of patient-centered care.
Patient-centered care has been getting a lot of attention as the healthcare industry focuses on the Triple Aim of delivering better health outcomes, improving patient experience, and reducing the cost of care. In that vein, the Louis W. Sullivan Institute for Healthcare Innovation recently released 6 guiding principles of patient-centered care.
The principles were created by the Sullivan Institute’s Patient Experience Council, a collective body of ePatients and eAdvocates, and presented at WEDI-Con 2014 in Reston, VA.
“As healthcare stakeholders explore strategies to deliver more patient-centric care, products and services, we see these Guiding Principles serving as the next step to ensuring that the patient engagement strategies being considered result in patient-experience centered outcomes,” Kym Martin, MBA, CNC, CFT, co-chair of The Sullivan Institute’s Patient Experience Council, said in a statement.
The principles expand upon the Institute of Medicine’s definition of patient-centered care in an attempt to aid stakeholders to strengthen patient-centered efforts and include:
According to the Patient Experience Council, patient-centered care and these 6 guiding principles can not only improve quality, safety, and patient satisfaction, but also healthcare professional satisfaction, which reduces turnover and burnout.
“I believe that the principles being released today by our Patient Experience Council will help provide a framework for how organizations should orient their efforts in order to prepare for the future landscape of healthcare,” WEDI President and Chief Executive Officer Devin Jopp, EdD, said.
See full explanations for the guiding principles here: http://bit.ly/1rrCCpl
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Racial Differences in CA-125 Levels Tied to Ovarian Cancer Treatment Delays
April 17th 2025Black and American Indian women with ovarian cancer were less likely to have elevated cancer antigen 125 (CA-125) levels at diagnosis, resulting in delayed chemotherapy initiation and highlighting the need for more inclusive guidelines.
Read More